arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

OCULAR THERAPEUTIX, INC

OCUL

$6.42 ▼ -0.73 (-10.21%) at close

15 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

OCULAR THERAPEUTIX, INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B

Dividend Yield —

Revenue Growth -18.5% ↘

Op. Margin None

ROIC -32.6% ↗

FCF / Share $-1.16 ↘

Trailing P/E —

Price / Book 2.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$51.95M

↓ -18.5% —

Net Income Profit after all expenses

$-265.94M

↓ -37.4% —

Operating Margin Operating profit as % of sales

-269.6%

↓ -91.2% —

FCF / Share Free cash flow per share

$-1.16

↓ -34.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	-18.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-331%)	9.0% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+13%)	13.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+69%)	18.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+129%)	150.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1776%)	311.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3796%)	112.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1305%)	3.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-56%)	1.9% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-76%)	7.8% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	126.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1484%)	—	—	—	—
EPS Growth YoY (%)	-16.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-20.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-9.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-922.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	96.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-37.4% Weak ↑ Weak Improving Year-over-year change in net income	-139.7% Weak ↑ Weak Improving Year-over-year change in net income	-13.7% Weak ↑ Weak Improving Year-over-year change in net income	-984.1% Weak ↓ Weak Declining Year-over-year change in net income	95.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-80.2% Weak ↓ Weak Declining Year-over-year change in net income	-44.0% Weak ↓ Weak Declining Year-over-year change in net income	5.4% Fair ↑ Fair Improving Year-over-year change in net income	-41.8% Weak ↑ Weak Improving Year-over-year change in net income	-12.5% Weak ↑ Weak Improving Year-over-year change in net income	-38.7% Weak ↑ Weak Improving Year-over-year change in net income	-115.1% Weak Weak Year-over-year change in net income	5.5% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	-34.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	10.1% Fair ↑ Fair Improving Year-over-year change in free cash flow	-16.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	5.7% Fair Fair Year-over-year change in free cash flow	2.4% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	0.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	13.6% Good ↓ Good Declining Compound annual revenue growth over 3 years	49.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	130.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	179.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	108.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	30.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	4.4% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	35.6% Excellent Excellent Compound annual revenue growth over 3 years	—	459.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	24.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	72.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	96.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	93.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	87.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	58.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	40.5% Excellent Excellent Compound annual revenue growth over 5 years	—	186.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	—	-269.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1897%)	-141.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1040%)	-152.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1118%)	-179.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1295%)	-361.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2508%)	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	-303.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2631%)	-138.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1251%)	-138.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1250%)	-15.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-225%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-417.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-213.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-130.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-123.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-153.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-312.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	10.19x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-32.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-43.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-71.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-175.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1867.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-130.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-187.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	17.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	23.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-109.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-80.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-111.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-67.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-40.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	-61.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-509%)	-88.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-691%)	-200.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1439%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-204.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1464%)	—	-167.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1215%)	-242.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1716%)	-86.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-673%)	-44.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-396%)	-48.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-425%)	22.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+49%)	30.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+102%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Interest Coverage (x)	-29.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-193.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.20x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-11.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-34.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-32.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.79x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-22.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-29.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-36.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-737.06M	$-392.10M	$-195.81M	$-102.30M	$-164.16M	$-228.06M	$-54.44M	$-54.06M	$-41.54M	$-32.94M	$-30.78M	$-37.39M	$-17.50M	$-23.85M	$-5.33M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$0.28	$0.40	$0.73	$0.67	$0.57	$0.29	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.42	$-1.22	$-1.01	$-0.92	$-0.09	$-2.56	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.16	$-0.86	$-0.96	$-0.82	$-0.87	$-0.90	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.03	$2.00	$0.79	$0.46	$1.15	$1.00	$-0.07	$0.86	$0.88	$2.08	$3.62	$2.75	$-22.22	—	—
Tangible Book Value per Share (USD)	$3.03	$2.00	$0.79	$0.46	$1.15	$1.00	$-0.07	$0.86	$0.88	$2.08	$3.62	$2.75	$-22.22	—	—
Basic Weighted Avg Shares (shares)	187.24M	158.27M	79.83M	76.88M	76.39M	60.75M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$731.32M	$399.63M	$197.34M	$98.23M	$164.96M	$219.50M	$48.14M	$47.03M	$29.91M	$61.60M	$101.61M	$70.31M	$14.67M	—	—
Total Equity (USD)	$654.31M	$315.34M	$91.13M	$35.38M	$88.00M	$76.09M	$-3.63M	$35.88M	$26.15M	$52.01M	$89.59M	$58.70M	$-59.47M	$-46.61M	$-32.73M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$51.95M	$63.72M	$58.44M	$51.49M	$43.52M	$17.40M	$4.23M	$1.99M	$1.92M	$1.89M	$1.75M	$772.00K	—	$10.00K	—
Depreciation Expense (USD)	$4.32M	$3.79M	$2.98M	$2.11M	$2.42M	$2.77M	$2.53M	$2.29M	$1.62M	$881.00K	$754.00K	$547.00K	$404.00K	$404.00K	—
Net Income, GAAP (USD)	$-265.94M	$-193.51M	$-80.74M	$-71.04M	$-6.55M	$-155.64M	$-86.37M	$-59.98M	$-63.39M	$-44.70M	$-39.75M	$-28.65M	$-13.32M	$-14.09M	—
Operating Cash Flow (USD)	$-204.88M	$-134.68M	$-70.23M	$-59.60M	$-65.55M	$-53.55M	$-77.58M	$-49.23M	$-50.47M	$-34.00M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 15 years · 56 quarters

OCULAR THERAPEUTIX, INC

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OCUL with peers